• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE HELEX SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE HELEX SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL Back to Search Results
Catalog Number HX2025
Device Problem Insufficient Information (3190)
Patient Problems Endocarditis (1834); Thrombus (2101)
Event Date 07/04/2014
Event Type  Injury  
Event Description
It was reported the physician implanted a 25mm gore helex septal occluder to close a patent foramen ovale on (b)(6) 2012.On (b)(6) 2014 the patient presented with endocarditis.Transesophageal echocardiography showed thrombus formation on both the left and right side of the device.On (b)(6) 2014 the device was surgically removed.
 
Manufacturer Narrative
A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.
 
Manufacturer Narrative
A cd containing echocardiographic images was received for review.Transthoracic echocardiography performed on (b)(6) 2014 revealed an echo dense mass located on the gore helex septal occluder.Further evaluation by transesophageal echocardiography on (b)(6) 2014 demonstrated the echo dense mass was attached to the right and left disc of the occluder.The echo dense masses were mobile and irregular in size.The masses covered most of the right and left discs and extended close to the mitral and tricuspid valves.On (b)(6) 2014, the patient was sent to surgery to have the occluder and the echo dense masses removed and the septum repaired with a surgical patch.According to the imaging analysis, the thrombus was first noted (b)(6) 2014.The initial reports has the date of event as (b)(6) 2014.
 
Manufacturer Narrative
A review of the sterilization records verified this lot met pre-released specification requirements.
 
Manufacturer Narrative
(b)(4).These corrections do not affect the manufacturing evaluation.The correct records were reviewed originally, and the review verified the lot was processed normally and all pre-release specifications were met.
 
Manufacturer Narrative
The explanted device and associated cardiac septum was returned for analysis.Histopathological examination of three tissue specimens were performed.A moderately thick mature collagenous neointima diffusely covered the surface of the left disc.The right disc was multifocally covered in neointima with areas of disc material exposed.Scanning electron microscopy was unable to confirm the presence of significant endothelialization of both the right and left disc surfaces.Neointima covering the left disc and hyperplastic intima of the cardiac septum were multifocally degraded and infiltrated by inflammatory cells, particularly neutrophils.Variably sized colonies of gram positive bacterial cocci colonized the device and cardiac tissue, with the right disc more severely affected.The device was subjected to an enzymatic digestion process to remove biologic debris.Following digestion the device was examined for material disruptions with the aid of a stereomicroscope.No wear related disruptions were identified.The physician stated he believed the endocarditis was a result of patient lifestyle and drug abuse; not device related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE HELEX SEPTAL OCCLUDER
Type of Device
OCCLUDER, TRANSCATHETER SEPTAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3958435
MDR Text Key4556637
Report Number2017233-2014-00373
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 01/26/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2014
Device Catalogue NumberHX2025
Device Lot Number8787173A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/21/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/25/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Not provided
Supplement Dates FDA Received09/17/2014
01/23/2015
02/04/2015
02/05/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age35 YR
Patient Weight82
-
-